Neuroprotective Effects of 3,6′-Disinapoyl Sucrose Through Increased BDNF Levels and CREB Phosphorylation via the CaMKII and ERK1/2 Pathway von Hu, Yuan, Liu, Ming-Yue, Liu, Ping, Dong, XianZhe, Boran, Aislyn D. W.

Volltext

A potential peptide therapeutic derived from the juxtamembrane domain of the epidermal growth factor receptor von Boran, Aislyn D W, Seco, Joseph, Jayaraman, Vinodh, Jayaraman, Gomathi, Zhao, Shan, Reddy, Sushmitha, Chen, Yibang, Iyengar, Ravi

Volltext

Recovering protein-protein and domain-domain interactions from aggregation of IP-MS proteomics of coregulator complexes von Mazloom, Amin R, Dannenfelser, Ruth, Clark, Neil R, Grigoryan, Arsen V, Linder, Kathryn M, Cardozo, Timothy J, Bond, Julia C, Boran, Aislyn D W, Iyengar, Ravi, Malovannaya, Anna, Lanz, Rainer B, Ma'ayan, Avi

Volltext

Identification of new G beta gamma interaction sites in adenylyl cyclase 2 von Boran, Aislyn DW, Chen, Yibang, Iyengar, Ravi

Volltext

Systems Pharmacology von Boran, Aislyn D. W., Iyengar, Ravi

Volltext

Identification of new Gβγ interaction sites in adenylyl cyclase 2 von Boran, Aislyn D.W., Chen, Yibang, Iyengar, Ravi

Volltext

Recovering Protein-Protein and Domain-Domain Interactions from Aggregation of IP-MS Proteomics of Coregulator Complexes: e1002319 von Mazloom, Amin R, Dannenfelser, Ruth, Clark, Neil R, Grigoryan, Arsen V, Linder, Kathryn M, Cardozo, Timothy J, Bond, Julia C, Boran, Aislyn DW, Iyengar, Ravi, Malovannaya, Anna, Lanz, Rainer B

Volltext

Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial von Subbiah, Vivek, Lassen, Ulrik, Élez, Elena, Italiano, Antoine, Curigliano, Giuseppe, Javle, Milind, de Braud, Filippo, Prager, Gerald W, Greil, Richard, Stein, Alexander, Fasolo, Angelica, Schellens, Jan H M, Wen, Patrick Y, Viele, Kert, Boran, Aislyn D, Gasal, Eduard, Burgess, Paul, Ilankumaran, Palanichamy, Wainberg, Zev A

Volltext

Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial von Wen, Patrick Y, Stein, Alexander, van den Bent, Martin, De Greve, Jacques, Wick, Antje, de Vos, Filip Y F L, von Bubnoff, Nikolas, van Linde, Myra E, Lai, Albert, Prager, Gerald W, Campone, Mario, Fasolo, Angelica, Lopez-Martin, Jose A, Kim, Tae Min, Mason, Warren P, Hofheinz, Ralf-Dieter, Blay, Jean-Yves, Cho, Daniel C, Gazzah, Anas, Pouessel, Damien, Yachnin, Jeffrey, Boran, Aislyn, Burgess, Paul, Ilankumaran, Palanichamy, Gasal, Eduard, Subbiah, Vivek

Volltext

Dabrafenib plus trametinib in patients with BRAF V600E -mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial von Subbiah, Vivek, Lassen, Ulrik, Élez, Elena, Italiano, Antoine, Curigliano, Giuseppe, Javle, Milind, de Braud, Filippo, Prager, Gerald W, Greil, Richard, Stein, Alexander, Fasolo, Angelica, Schellens, Jan H M, Wen, Patrick Y, Viele, Kert, Boran, Aislyn D, Gasal, Eduard, Burgess, Paul, Ilankumaran, Palanichamy, Wainberg, Zev A

Volltext